Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
In 2023, US diabetes patients encountered difficulties accessing insulin as major drug manufacturers reported periodic ...
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery - Observed weight loss was 17% at 28 days, a 25% ...
the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need steady access to short-acting insulin. Which insulin brands are in ...
“It doesn’t ever stop.” People with type 1 and some with type 2 can face multiple daily injections of insulin. Short-acting insulin covers the spike in glucose that comes with meal ...
23 letters to CEOs of the three pharmaceutical giants, the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need short-acting ...